K212595 is an FDA 510(k) clearance for the Erchonia FX-405. Classified as Powered Light Based Laser Non-thermal Instrument With Non-heating Effect For Adjunctive Use In Pain Therapy (product code NHN), Class II - Special Controls.
Submitted by Erchonia Corporation (Melbourne, US). The FDA issued a Cleared decision on November 12, 2021 after a review of 88 days - a notably fast clearance cycle.
This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.5500 - the FDA physical medicine device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Erchonia Corporation devices